The US Food and Drug Administration in a statement said the products manufactured by Pune-based Jash International - Sutra Bidis Red, Sutra Bidis Menthol, Sutra Bidis Red Cone and Sutra Bidis Menthol Cone - were found to be not substantially equivalent to tobacco products commercially marketed.
The ban is first one issued by the FDA under the 2009 Family Smoking Prevention and Tobacco Control Act.
This means they can no longer be sold or distributed in interstate commerce or imported into the United States, the FDA said.
The regulator said under the Under the Tobacco Control Act, Jash International did not identify eligible predicate tobacco products as required for the FDA to perform an substantially equivalent (SE) review.
Also, the company did not provide information necessary to determine whether the new products had the same characteristics as that of its previous products, or had different characteristics but did not raise different questions of public health, the basis used by the FDA to review SE applications, it said.
"Because the company failed to meet the requirement of the Tobacco Control Act, the FDA's decision means that, regardless of when the products were manufactured, these four products can no longer be legally imported or sold or distributed through interstate commerce in the United States," the official said.
Existing inventory may be subject to enforcement action, including seizure, without further notice. Companies that continue to sell and distribute these products in the United States may be subject to enforcement actions by the FDA, the statement said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
